Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Japan health ministry has approved low-cost and widely available steroid drug, dexamethasone, for the treatment of patients suffering from Covid-19.
This marks the second approval for a Covid-19 treatment in the country, following the authorisation of Gilead Sciences’ antiviral drug remdesivir in May.
The Health, Labor and Welfare Ministry included dexamethasone as a government-approved drug in a recent version of its handbook for novel coronavirus treatment, reported Japan Times.
According to the revised handbook, dexamethasone showed promise in a clinical study performed by the University of Oxford in the UK.